NSC |
Compound |
Enrichment |
Correlation |
NSC 693563 |
Null |
0.0306776553926119 |
0.46103607 |
NSC 698065 |
Null |
0.0306776553926119 |
-0.27918774 |
NSC 699081 |
Null |
0.0306776553926119 |
0.38211741 |
NSC 703823 |
3-Hydroxy-16(4'-pyridylmethylene)-17-oxo-1,3,5(10)-estratriene |
0.0306776553926119 |
0.49817288 |
NSC 707465 |
2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- |
0.0306776553926119 |
0.35577931 |
NSC 708416 |
Null |
0.0306776553926119 |
0.31302109 |
NSC 728132 |
1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,4-dichlorobenzene |
0.0306776553926119 |
0.28410358 |
NSC 732517 |
Dasatinib |
0.0306776553926119 |
-0.25561508 |
NSC 732698 |
1-{4-[4-chloro-1-(2,4-dichlorobenzyl)-2,5-dioxo-2,5-dihydro- 1H-3-pyrrolylamino]phenylcarboxamido}-3-trifluoromethylbenze ne |
0.0306776553926119 |
0.33373434 |
NSC 736079 |
4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine |
0.0306776553926119 |
0.3354024 |